| Literature DB >> 7030442 |
M Peet, M S Bethell, A Coates, A K Khamnee, P Hall, S J Cooper, D J King, R A Yates.
Abstract
Fifty-three hospitalized chronic schizophrenic patients were treated with either propranolol, chlorpromazine or placebo in a double-blind randomized trials for up to three months. Propranolol in a usual dose of 640 mg/day, produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo. The effects of chlorpromazine were small and inconsistent.Entities:
Mesh：
Substances：
Year: 1981 PMID： 7030442 DOI： 10.1192/bjp.139.2.105
Source DB: PubMed Journal: Br J Psychiatry ISSN： 0007-1250 Impact factor: 9.319